Profile
Mr. Gerhard Musshafen is a Director at Neurotune AG and Chairman at Prionics AG.
Mr. Musshafen was previously employed as Founder by HealthCare Partners LLC, a Member-Executive Board by Immuno AG, and a Principal by Boehringer Mannheim GmbH.
He received his undergraduate degree from Universität Stuttgart.
Former positions of Gerhard Musshafen
| Companies | Position | End |
|---|---|---|
HealthCare Partners LLC
HealthCare Partners LLC Medical DistributorsDistribution Services Provides medical equipment and supplies | Founder | 01/01/2005 |
Immuno AG | Corporate Officer/Principal | 01/01/1995 |
Roche Diagnostics GmbH
Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Develops innovative medicines, treatments and diagnostics | Corporate Officer/Principal | 01/01/1994 |
Prionics AG
Prionics AG Medical SpecialtiesHealth Technology Develops and wholesales diagnostic solutions for farm animal diseases | Chairman | - |
Neurotune AG
Neurotune AG Pharmaceuticals: MajorHealth Technology Develops medications for neuropathic pain and sarcopenia | Corporate Officer/Principal | - |
Training of Gerhard Musshafen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Prionics AG
Prionics AG Medical SpecialtiesHealth Technology Develops and wholesales diagnostic solutions for farm animal diseases | Health Technology |
HealthCare Partners LLC
HealthCare Partners LLC Medical DistributorsDistribution Services Provides medical equipment and supplies | Distribution Services |
Roche Diagnostics GmbH
Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Develops innovative medicines, treatments and diagnostics | Commercial Services |
Universität Stuttgart
Universität Stuttgart Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neurotune AG
Neurotune AG Pharmaceuticals: MajorHealth Technology Develops medications for neuropathic pain and sarcopenia | Health Technology |
Immuno AG |
- Stock Market
- Insiders
- Gerhard Musshafen
















